These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 17311371)

  • 21. The activation mechanism of chemokine receptor CCR5 involves common structural changes but a different network of interhelical interactions relative to rhodopsin.
    Springael JY; de Poorter C; Deupi X; Van Durme J; Pardo L; Parmentier M
    Cell Signal; 2007 Jul; 19(7):1446-56. PubMed ID: 17320349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Building three-dimensional structures of HIV-1 coreceptor CCR5 and its interaction with antagonist TAK779 by comparative molecular modeling.
    Huang XQ; Jiang HL; Luo XM; Chen KX; Ji RY; Cao Y; Pei G
    Acta Pharmacol Sin; 2000 Jun; 21(6):521-8. PubMed ID: 11360686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Computational study of CCR5 antagonist with support vector machines and three dimensional quantitative structure activity relationship methods.
    Chen Y; Li Z; Chen HF
    Chem Biol Drug Des; 2010 Mar; 75(3):295-309. PubMed ID: 20331647
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elucidation of binding sites of dual antagonists in the human chemokine receptors CCR2 and CCR5.
    Hall SE; Mao A; Nicolaidou V; Finelli M; Wise EL; Nedjai B; Kanjanapangka J; Harirchian P; Chen D; Selchau V; Ribeiro S; Schyler S; Pease JE; Horuk R; Vaidehi N
    Mol Pharmacol; 2009 Jun; 75(6):1325-36. PubMed ID: 19297521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular modeling of histamine H3 receptor and QSAR studies on arylbenzofuran derived H3 antagonists.
    Dastmalchi S; Hamzeh-Mivehroud M; Ghafourian T; Hamzeiy H
    J Mol Graph Model; 2008 Jan; 26(5):834-44. PubMed ID: 17561422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of peptide ligands to the chemokine receptor CCR5 and their maturation by gene shuffling.
    Vyroubalova EC; Hartley O; Mermod N; Fisch I
    Mol Immunol; 2006 Apr; 43(10):1573-8. PubMed ID: 16280164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of novel HIV entry inhibitors for the CXCR4 receptor by prospective virtual screening.
    Pérez-Nueno VI; Pettersson S; Ritchie DW; Borrell JI; Teixidó J
    J Chem Inf Model; 2009 Apr; 49(4):810-23. PubMed ID: 19358515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chapter 12. The use of receptor homology modeling to facilitate the design of selective chemokine receptor antagonists.
    Carter PH; Tebben AJ
    Methods Enzymol; 2009; 461():249-79. PubMed ID: 19480923
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery of bioavailable 4,4-disubstituted piperidines as potent ligands of the chemokine receptor 5 and inhibitors of the human immunodeficiency virus-1.
    Kazmierski WM; Aquino C; Chauder BA; Deanda F; Ferris R; Jones-Hertzog DK; Kenakin T; Koble CS; Watson C; Wheelan P; Yang H; Youngman M
    J Med Chem; 2008 Oct; 51(20):6538-46. PubMed ID: 18811134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacophore modeling and in silico screening for new KDR kinase inhibitors.
    Yu H; Wang Z; Zhang L; Zhang J; Huang Q
    Bioorg Med Chem Lett; 2007 Apr; 17(8):2126-33. PubMed ID: 17306530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CCR5 antagonists as anti-HIV-1 agents. Part 3: Synthesis and biological evaluation of piperidine-4-carboxamide derivatives.
    Imamura S; Nishikawa Y; Ichikawa T; Hattori T; Matsushita Y; Hashiguchi S; Kanzaki N; Iizawa Y; Baba M; Sugihara Y
    Bioorg Med Chem; 2005 Jan; 13(2):397-416. PubMed ID: 15598561
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nonpeptide Urotensin-II receptor agonists and antagonists: review and structure-activity relationships.
    Lescot E; Bureau R; Rault S
    Peptides; 2008 May; 29(5):680-90. PubMed ID: 18022732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of novel serotonin 2C receptor ligands by sequential virtual screening.
    Ahmed A; Choo H; Cho YS; Park WK; Pae AN
    Bioorg Med Chem; 2009 Jul; 17(13):4559-68. PubMed ID: 19464901
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The discovery of tropane-derived CCR5 receptor antagonists.
    Armour DR; de Groot MJ; Price DA; Stammen BL; Wood A; Perros M; Burt C
    Chem Biol Drug Des; 2006 Apr; 67(4):305-8. PubMed ID: 16629828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural insights from binding poses of CCR2 and CCR5 with clinically important antagonists: a combined in silico study.
    Kothandan G; Gadhe CG; Cho SJ
    PLoS One; 2012; 7(3):e32864. PubMed ID: 22479344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Homology modeling of the serotonin 5-HT1A receptor using automated docking of bioactive compounds with defined geometry.
    Nowak M; Kołaczkowski M; Pawłowski M; Bojarski AJ
    J Med Chem; 2006 Jan; 49(1):205-14. PubMed ID: 16392805
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of a postendocytic sorting sequence in CCR5.
    Delhaye M; Gravot A; Ayinde D; Niedergang F; Alizon M; Brelot A
    Mol Pharmacol; 2007 Dec; 72(6):1497-507. PubMed ID: 17855654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure-based approach to pharmacophore identification, in silico screening, and three-dimensional quantitative structure-activity relationship studies for inhibitors of Trypanosoma cruzi dihydrofolate reductase function.
    Schormann N; Senkovich O; Walker K; Wright DL; Anderson AC; Rosowsky A; Ananthan S; Shinkre B; Velu S; Chattopadhyay D
    Proteins; 2008 Dec; 73(4):889-901. PubMed ID: 18536013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integration of virtual screening with high-throughput flow cytometry to identify novel small molecule formylpeptide receptor antagonists.
    Edwards BS; Bologa C; Young SM; Balakin KV; Prossnitz ER; Savchuck NP; Sklar LA; Oprea TI
    Mol Pharmacol; 2005 Nov; 68(5):1301-10. PubMed ID: 16118363
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of CCR5 receptor binding affinity of substituted 1-(3,3-diphenylpropyl)-piperidinyl amides and ureas based on the heuristic method, support vector machine and projection pursuit regression.
    Yuan Y; Zhang R; Hu R; Ruan X
    Eur J Med Chem; 2009 Jan; 44(1):25-34. PubMed ID: 18433938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.